ShaTin, Hong Kong – Cofttek is pleased to announce it is the leading manufacturer of small molecule anticancer reagents and kinase inhibitors.
Cofttek has been providing outstanding custom synthesis and manufacturing services for the last 10 years. They specialize in providing a service range from small batch milligrams, to metric tons of large-scale amounts.
“When we started the company, it was important for us to meet the unique needs of all our clients,” says King Zhang, one of Cofttek’s founding members. “As such, we can customize the supply chain for production chemistry to meet our clients’ specific project deliverables, with optimal speed and cost.”
Though Cofttek’s is able to produce large batches of reagents and inhibitors with great speed and affordable prices, the company does not sacrifice quality. All manufacturing of products is performed in their wholly-owned manufacturing facility, giving chemists the ability to strictly meet regulatory standards.
Cofttek offers the following services, all of which are underpinned by strong policies on Intellectual Property (IP) protection:
“We have an excellent track record of solving complex organic synthesis challenges for our customers,” says Zhang. “Projects can be based on full-time equivalents or even daily rates. This is just one of the many reasons we are a world leading manufacturer.”
The majority of Cofttek’s clients are located in North America, Europe, and Asia, and include well known brands such as Pfizer, Lilly, Roche, GSK, MSD and Bayer.
For more information about Cofttek, or to place an order, please visit their website at https://www.cofttek.com/
Media ContactCompany Name: CofttekContact Person: King ZhangEmail: Send EmailPhone: +86 (1892) 9367792Country: HongKongWebsite: https://www.cofttek.com
